Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001419121 | SCV001621366 | likely benign | Tuberous sclerosis 2 | 2023-10-23 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004804168 | SCV005427199 | likely benign | Tuberous sclerosis syndrome | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004951715 | SCV005523408 | likely benign | Hereditary cancer-predisposing syndrome | 2024-07-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |